299 related articles for article (PubMed ID: 22264668)
1. French results of the ARESC study: clinical aspects and epidemiology of antimicrobial resistance in female patients with cystitis. Implications for empiric therapy.
Neuzillet Y; Naber KG; Schito G; Gualco L; Botto H
Med Mal Infect; 2012 Feb; 42(2):66-75. PubMed ID: 22264668
[TBL] [Abstract][Full Text] [Related]
2. Surveillance study in Europe and Brazil on clinical aspects and Antimicrobial Resistance Epidemiology in Females with Cystitis (ARESC): implications for empiric therapy.
Naber KG; Schito G; Botto H; Palou J; Mazzei T
Eur Urol; 2008 Nov; 54(5):1164-75. PubMed ID: 18511178
[TBL] [Abstract][Full Text] [Related]
3. [Uncomplicated lower urinary tract infections in females--clinical aspects, aetiology and antimicrobial resistance epidemiology. Results of the ARESC (Antimicrobial Resistance Epidemiological Survey on Cystitis) study in Poland and their implications for empiric therapy].
Chlabicz S; Leszczynska K; Lukas W; Gualco L; Schito G; Naber KG
Przegl Epidemiol; 2011; 65(2):345-51. PubMed ID: 21913487
[TBL] [Abstract][Full Text] [Related]
4. [Clinical aspects and epidemiology of uncomplicated cystitis in women. German results of the ARESC Study].
Wagenlehner FM; Wagenlehner C; Savov O; Gualco L; Schito G; Naber KG
Urologe A; 2010 Feb; 49(2):253-61. PubMed ID: 19943031
[TBL] [Abstract][Full Text] [Related]
5. [Russian results of the international epidemiological study of clinical aspects and resistance to antimicrobial medicines of cystitis uropathogens in females (ARESC): significance of empiric therapy].
Perepanova TS; Siniakova LA; Zaĭtsev AV; Kozlov RS; Shevelev AN; Gualco L; Achito G; Naber KG
Urologiia; 2011; (2):30-6. PubMed ID: 21815455
[TBL] [Abstract][Full Text] [Related]
6. The ARESC study: an international survey on the antimicrobial resistance of pathogens involved in uncomplicated urinary tract infections.
Schito GC; Naber KG; Botto H; Palou J; Mazzei T; Gualco L; Marchese A
Int J Antimicrob Agents; 2009 Nov; 34(5):407-13. PubMed ID: 19505803
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial resistance among uropathogens that cause acute uncomplicated cystitis in women in Hong Kong: a prospective multicenter study in 2006 to 2008.
Ho PL; Yip KS; Chow KH; Lo JY; Que TL; Yuen KY
Diagn Microbiol Infect Dis; 2010 Jan; 66(1):87-93. PubMed ID: 19446980
[TBL] [Abstract][Full Text] [Related]
8. [Etiology and sensitivity of uropathogens identified in uncomplicated lower urinary tract infections in women (ARESC Study): implications on empiric therapy].
Palou J; Pigrau C; Molina I; Ledesma JM; Angulo J;
Med Clin (Barc); 2011 Jan; 136(1):1-7. PubMed ID: 20889171
[TBL] [Abstract][Full Text] [Related]
9. Other antimicrobials of interest in the era of extended-spectrum beta-lactamases: fosfomycin, nitrofurantoin and tigecycline.
Garau J
Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():198-202. PubMed ID: 18154548
[TBL] [Abstract][Full Text] [Related]
10. Activity of fosfomycin and comparison of several susceptibility testing methods against contemporary urine isolates.
Hirsch EB; Raux BR; Zucchi PC; Kim Y; McCoy C; Kirby JE; Wright SB; Eliopoulos GM
Int J Antimicrob Agents; 2015 Dec; 46(6):642-7. PubMed ID: 26498988
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial susceptibility of Gram-negative uropathogens isolated from obstetric patients.
Jamie WE; Edwards RK; Duff P
Infect Dis Obstet Gynecol; 2002; 10(3):123-6. PubMed ID: 12625967
[TBL] [Abstract][Full Text] [Related]
12. Extended-spectrum β-lactamase-producing Enterobacteriaceae: in vitro susceptibility to fosfomycin, nitrofurantoin and tigecycline.
Al-Zarouni M; Senok A; Al-Zarooni N; Al-Nassay F; Panigrahi D
Med Princ Pract; 2012; 21(6):543-7. PubMed ID: 22722224
[TBL] [Abstract][Full Text] [Related]
13. Isolation of fluoroquinolone-resistant rectal Escherichia coli after treatment of acute uncomplicated cystitis.
Gupta K; Hooton TM; Stamm WE
J Antimicrob Chemother; 2005 Jul; 56(1):243-6. PubMed ID: 15911548
[TBL] [Abstract][Full Text] [Related]
14. Acute uncomplicated cystitis: from surveillance data to a rationale for empirical treatment.
Katsarolis I; Poulakou G; Athanasia S; Kourea-Kremastinou J; Lambri N; Karaiskos E; Panagopoulos P; Kontopidou FV; Voutsinas D; Koratzanis G; Kanellopoulou M; Adamis G; Vagiakou H; Perdikaki P; Giamarellou H; Kanellakopoulou K;
Int J Antimicrob Agents; 2010 Jan; 35(1):62-7. PubMed ID: 19906513
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial susceptibility of clinical Escherichia coli isolates from uncomplicated cystitis in women over a 1-year period in Spain.
Gobernado M; Valdés L; Alós JI; García-Rey C; Dal-Ré R; García-de-Lomas J;
Rev Esp Quimioter; 2007 Mar; 20(1):68-76. PubMed ID: 17530038
[TBL] [Abstract][Full Text] [Related]
16. [Uncomplicated urinary tract infection and treatment].
Wagenlehner FM; Vahlensieck W; Watermann D; Weidner W; Naber KG
Aktuelle Urol; 2011 Jan; 42(1):33-7. PubMed ID: 21267803
[TBL] [Abstract][Full Text] [Related]
17. The ECO.SENS Project: a prospective, multinational, multicentre epidemiological survey of the prevalence and antimicrobial susceptibility of urinary tract pathogens--interim report.
Kahlmeter G
J Antimicrob Chemother; 2000 Sep; 46 Suppl 1():15-22; discussion 63-5. PubMed ID: 11051619
[TBL] [Abstract][Full Text] [Related]
18. Antimicrobial susceptibilities of urinary extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae to fosfomycin and nitrofurantoin in a teaching hospital in Taiwan.
Liu HY; Lin HC; Lin YC; Yu SH; Wu WH; Lee YJ
J Microbiol Immunol Infect; 2011 Oct; 44(5):364-8. PubMed ID: 21524974
[TBL] [Abstract][Full Text] [Related]
19. Increasing prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in women.
Gupta K; Scholes D; Stamm WE
JAMA; 1999 Feb; 281(8):736-8. PubMed ID: 10052444
[TBL] [Abstract][Full Text] [Related]
20. Second nationwide surveillance of bacterial pathogens in patients with acute uncomplicated cystitis conducted by Japanese Surveillance Committee from 2015 to 2016: antimicrobial susceptibility of Escherichia coli, Klebsiella pneumoniae, and Staphylococcus saprophyticus.
Hayami H; Takahashi S; Ishikawa K; Yasuda M; Yamamoto S; Wada K; Kobayashi K; Hamasuna R; Minamitani S; Matsumoto T; Kiyota H; Tateda K; Sato J; Hanaki H; Masumori N; Nishiyama H; Miyazaki J; Fujimoto K; Tanaka K; Uehara S; Matsubara A; Ito K; Hayashi K; Kurimura Y; Ito S; Takeuchi T; Narita H; Izumitani M; Nishimura H; Kawahara M; Hara M; Hosobe T; Takashima K; Chokyu H; Matsumura M; Ihara H; Uno S; Monden K; Sumii T; Kawai S; Kariya S; Sato T; Yoshioka M; Kadena H; Matsushita S; Nishi S; Hosokawa Y; Shirane T; Yoh M; Watanabe S; Makinose S; Uemura T; Goto H
J Infect Chemother; 2019 Jun; 25(6):413-422. PubMed ID: 30905628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
